Last reviewed · How we verify

NCT03866616

Evaluation Study of the Impact of the New Brain Builders Parenting Class

Terminated NA Last updated 12 August 2020
What this trial tests

NA trial testing Brain Builders Parenting Class in Child Development in 145 participants. Terminated before completion.

Timeline
24 June 2019
Primary endpoint
15 December 2019
15 December 2019

Quick facts

Lead sponsorWilliam Marsh Rice University
PhaseNA
StatusTerminated
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment145
Start date24 June 2019
Primary completion15 December 2019
Estimated completion15 December 2019
Sites2 locations across United States

Drugs / interventions tested

Conditions studied

Sponsor

William Marsh Rice University

Who can join

18 and older, any sex, with Child Development or Mother-Child Interaction. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The objective of this research is to evaluate the effectiveness of the parenting program on increasing positive parent-child interactions and increasing cognitive achievement in children. Overall, this project is intended to benefit women and children and supplement WIC services. The Brain Builders Parenting Class Evaluation Study Research Questions include the following: 1. Does the program impact child development outcomes such as kindergarten readiness? 2. Does the program increase parental knowledge about the importance of high-quality parent-child interaction for child development? 3. Does the program impact the quality and quantity of the parent-child interactions?

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Child Development

Currently open trials in the same condition.

Other William Marsh Rice University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03866616.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing